Home » Archive

Headline, SDBN Blog, SDBN Events »

Brewing Science: Improving Science Communication with ASBMB April 23rd At Mission Brewery

Posted by Mary Canady March 30th, 2012 .
No Comments

In April we’re teaming up with the American Society for Biochemistry and Molecular Biology (ASBMB) to host an event at Mission Brewery downtown during the big Experimental Biology conference. You may know we are big proponents of science communication because it helps researchers with their careers, funding, and connecting with other scientists.
The event will feature bloggers, reporters, industry professionals, public speaking experts, and policy makers, all who will be available to help you improve your science communication skills. We’ll have some fun contests to help you meet people, and there …

More...

Marketwire, News, Syndication »

Medistem Appoints Director of Chinese Operations

Posted by Mary Canady March 29th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 29, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced today the appointment of Feng Lin, MD, Ph.D as Director of Chinese Operations. Dr. Lin has an extensive background in basic research and therapeutics development…

More...

Marketwire, News, Syndication »

Mentor Capital to Discuss Major Cancer Funding, Low PE and Warrant Call at April 29 Shareholder Meeting

Posted by Mary Canady March 28th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 28, 2012) – Mentor Capital, Inc. (PINKSHEETS: MNTR) will hold its annual shareholders’ meeting at the company offices outside of San Diego, April 29, 2012 at 10:00AM. A management report and director ballots are being…

More...

Marketwire, News, Syndication »

Quidel Receives CE Mark for Its AmpliVue(TM) Hand-Held Molecular Diagnostic Test for Clostridium Difficile

Posted by Mary Canady March 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 27, 2012) – Quidel Corporation (NASDAQ: QDEL), announced today that it received CE mark for the AmpliVue C. difficile assay, its non-instrumented molecular test for the detection of toxigenic Clostridium difficile ba…

More...

Marketwire, News, Syndication »

Senomyx to Webcast Corporate Presentation at the 11th Annual Needham Healthcare Conference

Posted by Mary Canady March 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 27, 2012) – Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste science technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced to…

More...

Marketwire, News, Syndication »

Quidel Receives FDA Clearance for Its Quidel Molecular(TM) Influenza A+B Assay for Use With Cepheid SmartCycler(R)

Posted by Mary Canady March 22nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 22, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for i…

More...

Marketwire, News, Syndication »

Entest BioMedical Excited With Progress on 10 Dog Pilot Study of "Universal Donor" Stem Cell Treatment for Canine Osteoarthritis

Posted by Mary Canady March 21st, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 21, 2012) – Entest BioMedical Inc. (OTCQB: ENTB) (PINKSHEETS: ENTB)

Entest’s McDonald Animal Hospital has treated 8 dogs in 10 Dog Pilot Study.

All of which are showing pos…

More...

Marketwire, News, Syndication »

Medistem Shareholder Update: March 2012

Posted by Mary Canady March 20th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 20, 2012) – Medistem Inc. (PINKSHEETS: MEDS) today issues the following letter to shareholders.
Dear Fellow Shareholder:
Since our last update in December 2011, we would like to comment on several impo…

More...

Marketwire, News, Syndication »

Cytori Breast Reconstruction Cell Therapy Trial Results Published

Posted by Mary Canady March 19th, 2012 .
No Comments

ZUG, SWITZERLAND and SAN DIEGO, CA–(Marketwire – Mar 19, 2012) – Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
RESTORE-2 is a 71 pat…

More...

Marketwire, News, Syndication »

Cytori Breast Reconstruction Cell Therapy Trial Results Published

Posted by Mary Canady March 19th, 2012 .
No Comments

ZUG, SWITZERLAND and SAN DIEGO, CA–(Marketwire – Mar 19, 2012) – Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
RESTORE-2 is a 71 pat…

More...